Data as of Nov 13, 2026.

ShareEmbed

BMED holdings: all 56 positions

As of Nov 13, 2026, BMED’s top 10 holdings were 44.2% of the fund, led by Gilead Sciences at 5.83%. It held 56 positions.

Top 10 together
44.2%
Largest position
5.83%
Positions under 1%
19
The answerOne drawing that carries it.
By sector

What BMED holds

More

92% of the weight read, book dated 2026-11-13

The evidenceWhy, in charts and cards.
Know what you own

How concentrated the book is

The share of the fund in its largest positions, from the book dated Nov 13, 2026.

Showing Top 10.

Top 10 togetherof 56 positions
44.2%
Largest first

56 of 56 positions

Show all 62 rows
1Gilead SciencesGILD5.83%
2ModernaMRNA5.35%
3DanaherDHR5.19%
4AbbvieABBV4.94%
5Thermo Fisher ScientificTMO4.35%
6Edwards LifesciencesEW4.32%
7BiogenBIIB3.75%
8Mettler-Toledo International IncMTD3.64%
9Iqvia Holdings IncIQV3.51%
10Vertex PharmaceuticalsVRTX3.28%
11Merck & Co IncMRK3.00%
12Roche Ps Par AGROP2.84%
13Amgen IncAMGN2.57%
14Genmab Sponsored ADRGMAB2.56%
15Agilent Technologies IncA2.36%
16Neurocrine BiosciencesNBIX2.29%
17Waters CorpWAT2.25%
18Dexcom IncDXCM2.23%
19Argenx SE ADRARGX1.83%
20Halozyme TherapeuticsHALO1.75%
21Charles River Laboratories InternaCRL1.60%
22Teva Pharmaceutical IndustriesTEVA1.51%
23Intuitive SurgicalISRG1.49%
24Zimmer Biomet HoldingsZBH1.48%
25PfizerPFE1.46%
26Illumina IncILMN1.42%
27Galderma Group N AGGALD1.41%
28Roivant Sciences LtdROIV1.41%
29Bristol Myers SquibbBMY1.34%
30Abbott LaboratoriesABT1.31%
31Novartis AGNOVN1.29%
32Johnson & JohnsonJNJ1.28%
33Merck & Co IncMRK1.22%
34Guardant HealthGH1.22%
35Wuxi Biologics Cayman2269 HKG1.19%
36CytokineticsCYTK1.12%
37Biomarin PharmaceuticalBMRN1.00%
38Tempus Ai Class ATEM0.86%
39UCB SAUCB0.83%
40Protagonist TherapeuticsPTGX0.78%
41Axsome TherapeuticsAXSM0.70%
42BrukerBRKR0.70%
43Viridian Therapeutics OrsVRDN0.65%
44Alkermes Public Limited CompanyALKS0.62%
45Dianthus TherapeuticsDNTH0.56%
46PTC TherapeuticsPTCT0.44%
47MBX BiosciencesMBX0.43%
48Cogent BiosciencesCOGT0.36%
49Sagimet Biosciences Series ASGMT0.13%
50Summit TherapeuticsSMMT0.07%
51Eikon TherapeuticsEIKN0.06%
52Abiomed Cvrs0.00%
53Mirati Therapeutics IncMRTX0.00%
54Blueprint Medicines Corp0.00%
55Vigil Neuroscience Inc CvrDUMMY0.00%
56Korro Bio Inc CvrKRRBIO0.00%
BLK Csh Fnd Treasury Sl Agency4.96%
GBP Cash0.00%
HKD Cash0.00%
KRW Cash0.00%
USD Cash−2.73%
Cash and other net assets−0.01%
More

Source: iShares (BlackRock)’s daily holdings file. Data as of Nov 13, 2026. Updated each trading day. Last checked Nov 15, 2026.

About this book

Open the table
FundiShares Health Innovation Active ETF
Positions56
Holdings published for (the issuer’s daily file)Nov 13, 2026
SourceiShares (BlackRock) ↗
Top 10 together44.2%
Cash and other net assets2.22%

What this list is

Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract.

Sources

Get an alert

Email me when BMED's holdings change.

Confirm by email. One a day at most, and one click stops it. See Privacy.

Where to next

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, Holdings of BMED, data as of Nov 13, 2026. https://etfiq.com/funds/bmed/holdings/

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.